Aligos Therapeutics Inc (ALGS)
0.829
+0.01
(+0.66%)
USD |
NASDAQ |
Apr 24, 16:00
0.82
-0.01
(-1.09%)
After-Hours: 20:00
Aligos Therapeutics Shareholders Equity (Quarterly): 92.08M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 92.08M |
| September 30, 2023 | 54.82M |
| June 30, 2023 | 69.64M |
| March 31, 2023 | 84.75M |
| December 31, 2022 | 103.90M |
| September 30, 2022 | 122.01M |
| June 30, 2022 | 136.98M |
| March 31, 2022 | 152.89M |
| Date | Value |
|---|---|
| December 31, 2021 | 184.73M |
| September 30, 2021 | 217.01M |
| June 30, 2021 | 168.88M |
| March 31, 2021 | 195.22M |
| December 31, 2020 | 220.04M |
| September 30, 2020 | -136.67M |
| June 30, 2020 | 121.96M |
| December 31, 2019 | -64.89M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-136.67M
Minimum
Sep 2020
220.04M
Maximum
Dec 2020
107.71M
Average
121.99M
Median
Shareholders Equity (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | 248.67M |
| CEL-SCI Corp | 12.65M |
| AIM ImmunoTech Inc | 10.23M |
| IGC Pharma Inc | 9.053M |
| NovaBay Pharmaceuticals Inc | 3.314M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 151.53M |
| Total Liabilities (Quarterly) | 59.45M |
| Current Ratio | 5.902 |